Synergistic cytotoxicity of HDAC and PARP inhibitors and decitabine in pancreatic cancer cells: implications for novel therapy
“The results provide novel preclinical data that demonstrate synergism between HDACi- and PARPi-mediated inhibition of DNA repair and decitabine in...
